ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #302Top JournalHybrid

Seminars in Cancer Biology

Acronym:yscbi
•
Abbreviation (ISO):SEMIN. CANCER BIOL
•
Identifier (ISSN):1044-579X(Print)/1096-3650(Online)
•
Publisher:Academic Press Inc.
Clarivate IF (2026)
20.3↑ +4.6
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Seminars in Cancer Biology

WoS Q1
613192610.220189.66201911.1202015.7202117.0202214.5202312.1202415.7202520.32026
Annual Impact Factor Metric
Current (2026):20.3
Scopus SJR & RankScopus Q1
4.91
#302

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
202

202 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate2.5%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
192articles/year
30.52% Gold OA•83.6% Original Research

Aims & Scope

Seminars in Cancer Biology is a review journal dedicated to keeping scientists informed of developments in the field of molecular oncology on a topic by topic basis. Each issue is thematic in approach, devoted to an important topic of interest to cancer biologists, from the underlying genetic and molecular causes of cellular transformation and cancer to the molecular basis of potential therapies. Every issue is edited by a guest editor or editors, an internationally acknowledged expert(s) in the field, and contains approximately eight to twelve authoritative invited reviews on different aspects of the subject area. The aim of each issue is to provide a coordinated, readable, and lively review of a selected area, published rapidly to ensure currency.

Topics Covered (Recognized by AI)
Biology95.4%Genetics92.6%Medicine90.7%Internal medicine82.3%Chemistry79.5%Biochemistry77.9%Cancer69.2%Gene56.9%Cancer research54.4%Cell biology43.7%Immunology42.7%Pathology31.8%Immune system24.7%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ONCOLOGY

Q1
Rank18/333
IndexSCIE
JCISCIE2026

ONCOLOGY

Q1
Rank16/333
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF20.3
Articles / Year40
Total Citations63
2025
IF15.7
Articles / Year123
Total Citations962
2024
IF12.1
Articles / Year57
Total Citations1,364
2023
IF14.5
Articles / Year99
Total Citations5,006
2022
IF17.012
Articles / Year177
Total Citations11,960

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #302Scopus Q1SCImago Profile
Scopus Coverage:1990-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular Biology
Scopus Citation Rank (SJR)Q1
4.91

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
19.14

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,227 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations9,708
3-Year Documents517
Citable Documents493

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate47.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.5%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区ONCOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Seminars in Cancer Biology (acronym: yscbi, abbr: SEMIN. CANCER BIOL, ISSN: 1044-579X) is a peer-reviewed international scholarly journal in the field of Medicine, published by Academic Press Inc. in England since 1990. The periodical holds a Journal Impact Factor (JIF) of 20.3, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 4.910 (Q1), an H-index of 202.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 192 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $4,227 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Academic Press Inc.
Publication Language
English
Frequency
Bimonthly
Founding Year
1990
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD, 24-28 OVAL RD, LONDON, ENGLAND, NW1 7DX

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: daacfb01-a5b7-415b-be1c-dea20d4fafea
Database Updated: 2026-10-16